avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb1
|
ENSMUSG00000018973.2 | homeobox B1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb1 | mm10_v2_chr11_+_96365752_96365752 | 0.17 | 3.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0060032 | notochord regression(GO:0060032) |
0.5 | 1.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 7.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 4.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.8 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 2.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 1.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.4 | GO:1900738 | psychomotor behavior(GO:0036343) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 1.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 4.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.7 | GO:2000138 | vitamin D receptor signaling pathway(GO:0070561) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.0 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 1.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.0 | 0.7 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.9 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 1.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 5.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.9 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 5.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 7.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 4.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 1.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 4.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 1.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 2.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 5.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |